Pay in 4 interest-free payments of $6.45 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
For example, according to a study of over 41,000 adults with obesity, people taking tirzepatide: Were nearly twice as likely to lose at least 5% of their body weight than those taking semaglutide Were more than twice as likely to lose at least 10% of their body weight, and more than three times as likely to lose at least 15% of their body weight
It is not yet FDA approved, but Phase 3 data from the TRIUMPH-4 trial (December 2025) showed an average of 28.7% body weight loss at 68 weeks at the 12 mg dose the highest ever recorded in a pharmacological weight loss trial
Submit a complete PA request with a letter of medical necessity and supporting clinical documentation
If injectable semaglutide causes persistent injection site reactions for you, having the option to switch to oral drops without changing providers is a significant advantage
US$ 20.53
US$ 27.51
US$ 21.70
US$ 28.57
US$ 25.09
